Events & Presentations

GlycoMimetics CFO Brian Hahn Testifies Before House Capital Markets Subcommittee

12:00 AM ET

Additional Information

Brian Hahn, Chief Financial Officer of GlycoMimetics, Inc., provided testimony on March 22 on behalf of the Biotechnology Innovation Organization (BIO) before the House Subcommittee on Capital Markets and Government Sponsored Enterprises. Hahn serves as the Co-Chair of BIO’s Finance & Tax Committee. Read the full press release at